Unit Testing JavaScript

2 時間

Palvella shares surge 35% after rare skin disease drug meets trial goals

The Wayne biotech company is hoping its lead drug candidate becomes the first FDA-approved treatment of a rare skin disease.

一部の結果でアクセス不可の可能性があるため、非表示になっています。